Immunohistochemical evidence of CLIP2 in sporadic (left) and radiation induced (right) thyroid carcinoma. Credit: Helmholtz Zentrum München
The expression of the protein CLIP2 provides information on whether a papillary thyroid carcinoma was induced by radiation or had a sporadic origin. With this discovery, scientists from the Helmholtz Zentrum München have identified a new biomarker for the diagnosis of the cancer cause. Their findings have been published in the journal Oncogene.
CLIP2 serves as a radiation marker: After exposure to radiation from radioiodine, both the genetic activity and the protein expression are increased, as the scientists' studies were able to substantiate.
CLIP2 appears to be particularly significant in the development of tumours in the thyroid gland after radiation exposure. The team around Martin Selmansberger, Dr. Julia Heß, Dr. Kristian Unger and Prof. Dr. Horst Zitzelsberger from the Radiation Cytogenetics Research Unit at the Helmholtz Zentrum München discovered a connection between high CLIP2 levels and the radiation history of patients with papillary thyroid carcinoma. "In our study, we were able to verify radiation-associated CLIP2 expression at the protein level in three different cohorts of patients with thyroid carcinoma," reports first author Selmansberger. The research paper was prepared at the Helmholtz Zentrum München in cooperation with the Institute of Radiation Protection and the Analytical Pathology Research Unit.
Radiation marker CLIP2 allows distinction of cancer cause and risk assessment
"CLIP2 serves as a radiation marker and allows us to distinguish between radiation-induced and sporadic thyroid carcinomas," adds study leader Heß. In their investigations, the scientists developed a standardized method to determine the CLIP2 biomarker status. "This biomarker allows us both to draw conclusions about the mechanisms involved in the development of such tumours and to evaluate the risk of thyroid cancer after exposure to high level radiation, for instance, following a radiation accident," reports Heß.
The Helmholtz Zentrum München focuses its work in health research on major widespread diseases. In addition to diabetes and lung diseases, this also includes cancer. The objective of the Helmholtz Zentrum München is the rapid further development of the results of basic research in order to provide benefits for society.
The exact function of CLIP2 in the carcinogenesis of thyroid carcinoma is unknown. Reconstruction of the CLIP2 gene regulatory network suggests, however, that CLIP2 is involved in fundamental carcinogenic processes and that it consequently contributes to tumour development.
Explore further: Genetic factors behind radiation-induced thyroid cancer
More information: Selmansberger, M. et al. (2014). "CLIP2 as radiation biomarker in papillary thyroid carcinoma," Oncogene, DOI: 10.1038/onc.2014.311
Medical Xpress on facebook
Related Stories
Genetic factors behind radiation-induced thyroid cancer
Dec 04, 2013
Scientists have long sought to determine whether heredity is one of the factors responsible for increased risk of thyroid cancer, but their results have been inconclusive... until now.
New infrared marker for bio-imaging
Sep 09, 2014
The recently developed fluorescent protein Amrose is now being used for advanced near-IR imaging procedures. With the aid of a novel evolutionary platform technology, scientists at the Helmholtz Zentrum München have developed ...
Diabetes: A duo helps better
Aug 04, 2014
Metformin and SGLT2 inhibitors together reduce the blood sugar levels considerably more effectively than either drug alone. Scientists from the Helmholtz Zentrum München, partner in the German Center for Diabetes Research, ...
Metformin and SGLT2 inhibitors together effectively reduce the blood sugar levels
Aug 04, 2014
Metformin and SGLT2 inhibitors together reduce the blood sugar levels considerably more effectively than either drug alone. Scientists from the Helmholtz Zentrum München, partner in the German Center for Diabetes Research, ...
Liver cancer due to chronic inflammation: Tumour growth follows programmed cell death (apoptosis)
Aug 30, 2013
The death of numerous liver cells in the context of chronic inflammation due to apoptosis, a form of programmed cell death, can promote the formation of tumour cells in the liver. This insight significantly ...
Recommended for you
What to know if breast cancer runs in your family
41 minutes ago
Breast cancer is the second leading cause of death from cancer in women. A woman's lifetime risk of developing breast cancer is 12 percent (1 of every 8 women). Breast cancer risk is higher among women whose close blood relatives ...
Most liver cancer patients do not receive proper care
20 hours ago
Many US patients with liver cancer—even those with early stage disease that can often be cured—do not receive treatment for their disease, according to an analysis of studies published between 1989 and 2013.
Tumors might grow faster at night: Hormone that keeps us alert also suppresses the spread of cancer
22 hours ago
They emerge at night, while we sleep unaware, growing and spreading out as quickly as they can. And they are deadly. In a surprise finding that was recently published in Nature Communications, Weizmann Instit ...
'JAKing' up blood cancers, one cell at a time
22 hours ago
A solitary cell containing a unique abnormality can result in certain types of blood cancers known as myeloproliferative neoplasms (MPN), according to a study published in The Journal of Experimental Medicine.
Link between breast implants and cancer under investigation
22 hours ago
An international research group including Viennese pathologist Lukas Kenner has reviewed cases of possible association between breast implants and a form of lymphoma that may develop tumors at a later stage. The researchers ...
Mother of two volunteers to aid study seeking DNA patterns for breast cancer
Oct 03, 2014
After having two children in her 30s, Brianna Hinojosa-Flores had been vigilant about getting mammograms and performing breast self-exams, as suggested by her gynecologist. But when she ran for a congressional ...
User comments
© Medical Xpress 2011-2014, Science X network
Immunohistochemical evidence of CLIP2 in sporadic (left) and radiation induced (right) thyroid carcinoma. Credit: Helmholtz Zentrum München
The expression of the protein CLIP2 provides information on whether a papillary thyroid carcinoma was induced by radiation or had a sporadic origin. With this discovery, scientists from the Helmholtz Zentrum München have identified a new biomarker for the diagnosis of the cancer cause. Their findings have been published in the journal Oncogene.
CLIP2 serves as a radiation marker: After exposure to radiation from radioiodine, both the genetic activity and the protein expression are increased, as the scientists' studies were able to substantiate.
CLIP2 appears to be particularly significant in the development of tumours in the thyroid gland after radiation exposure. The team around Martin Selmansberger, Dr. Julia Heß, Dr. Kristian Unger and Prof. Dr. Horst Zitzelsberger from the Radiation Cytogenetics Research Unit at the Helmholtz Zentrum München discovered a connection between high CLIP2 levels and the radiation history of patients with papillary thyroid carcinoma. "In our study, we were able to verify radiation-associated CLIP2 expression at the protein level in three different cohorts of patients with thyroid carcinoma," reports first author Selmansberger. The research paper was prepared at the Helmholtz Zentrum München in cooperation with the Institute of Radiation Protection and the Analytical Pathology Research Unit.
Radiation marker CLIP2 allows distinction of cancer cause and risk assessment
"CLIP2 serves as a radiation marker and allows us to distinguish between radiation-induced and sporadic thyroid carcinomas," adds study leader Heß. In their investigations, the scientists developed a standardized method to determine the CLIP2 biomarker status. "This biomarker allows us both to draw conclusions about the mechanisms involved in the development of such tumours and to evaluate the risk of thyroid cancer after exposure to high level radiation, for instance, following a radiation accident," reports Heß.
The Helmholtz Zentrum München focuses its work in health research on major widespread diseases. In addition to diabetes and lung diseases, this also includes cancer. The objective of the Helmholtz Zentrum München is the rapid further development of the results of basic research in order to provide benefits for society.
The exact function of CLIP2 in the carcinogenesis of thyroid carcinoma is unknown. Reconstruction of the CLIP2 gene regulatory network suggests, however, that CLIP2 is involved in fundamental carcinogenic processes and that it consequently contributes to tumour development.
Explore further: Genetic factors behind radiation-induced thyroid cancer
More information: Selmansberger, M. et al. (2014). "CLIP2 as radiation biomarker in papillary thyroid carcinoma," Oncogene, DOI: 10.1038/onc.2014.311
Medical Xpress on facebook
Related Stories
Genetic factors behind radiation-induced thyroid cancer
Dec 04, 2013
Scientists have long sought to determine whether heredity is one of the factors responsible for increased risk of thyroid cancer, but their results have been inconclusive... until now.
New infrared marker for bio-imaging
Sep 09, 2014
The recently developed fluorescent protein Amrose is now being used for advanced near-IR imaging procedures. With the aid of a novel evolutionary platform technology, scientists at the Helmholtz Zentrum München have developed ...
Diabetes: A duo helps better
Aug 04, 2014
Metformin and SGLT2 inhibitors together reduce the blood sugar levels considerably more effectively than either drug alone. Scientists from the Helmholtz Zentrum München, partner in the German Center for Diabetes Research, ...
Metformin and SGLT2 inhibitors together effectively reduce the blood sugar levels
Aug 04, 2014
Metformin and SGLT2 inhibitors together reduce the blood sugar levels considerably more effectively than either drug alone. Scientists from the Helmholtz Zentrum München, partner in the German Center for Diabetes Research, ...
Liver cancer due to chronic inflammation: Tumour growth follows programmed cell death (apoptosis)
Aug 30, 2013
The death of numerous liver cells in the context of chronic inflammation due to apoptosis, a form of programmed cell death, can promote the formation of tumour cells in the liver. This insight significantly ...
Recommended for you
What to know if breast cancer runs in your family
41 minutes ago
Breast cancer is the second leading cause of death from cancer in women. A woman's lifetime risk of developing breast cancer is 12 percent (1 of every 8 women). Breast cancer risk is higher among women whose close blood relatives ...
Most liver cancer patients do not receive proper care
20 hours ago
Many US patients with liver cancer—even those with early stage disease that can often be cured—do not receive treatment for their disease, according to an analysis of studies published between 1989 and 2013.
Tumors might grow faster at night: Hormone that keeps us alert also suppresses the spread of cancer
22 hours ago
They emerge at night, while we sleep unaware, growing and spreading out as quickly as they can. And they are deadly. In a surprise finding that was recently published in Nature Communications, Weizmann Instit ...
'JAKing' up blood cancers, one cell at a time
22 hours ago
A solitary cell containing a unique abnormality can result in certain types of blood cancers known as myeloproliferative neoplasms (MPN), according to a study published in The Journal of Experimental Medicine.
Link between breast implants and cancer under investigation
22 hours ago
An international research group including Viennese pathologist Lukas Kenner has reviewed cases of possible association between breast implants and a form of lymphoma that may develop tumors at a later stage. The researchers ...
Mother of two volunteers to aid study seeking DNA patterns for breast cancer
Oct 03, 2014
After having two children in her 30s, Brianna Hinojosa-Flores had been vigilant about getting mammograms and performing breast self-exams, as suggested by her gynecologist. But when she ran for a congressional ...
User comments
© Medical Xpress 2011-2014, Science X network
0 comments:
Post a Comment